Selective CXCR4+Cancer Cell Targeting and Potent Antineoplastic Effect by a Nanostructured Version of Recombinant Ricin-Reference-Cited by-同舟云学术

Selective CXCR4+Cancer Cell Targeting and Potent Antineoplastic Effect by a Nanostructured Version of Recombinant Ricin

Published:2018-05-29 Issue:26 Volume:14 Page:1800665
ISSN:1613-6810
Container-title:Small
language:en
Short-container-title:Small

Author:

Díaz Raquel¹²³,Pallarès Victor⁴,Cano-Garrido Olivia¹²³,Serna Naroa¹²³,Sánchez-García Laura¹²³,Falgàs Aïda³⁴,Pesarrodona Mireia¹²³,Unzueta Ugutz³⁴,Sánchez-Chardi Alejandro⁵,Sánchez Julieta M.¹⁶,Casanova Isolda³⁴,Vázquez Esther¹²³,Mangues Ramón³⁴,Villaverde Antonio¹²³^ORCID

Affiliation:

1. Institut de Biotecnologia i de Biomedicina; Universitat Autònoma de Barcelona; Bellaterra 08193 Barcelona Spain

2. Departament de Genètica i de Microbiologia; Universitat Autònoma de Barcelona; Bellaterra 08193 Barcelona Spain

3. CIBER de Bioingeniería; Biomateriales y Nanomedicina (CIBER-BBN); Bellaterra 08193 Barcelona Spain

4. Biomedical Research Institute Sant Pau (IIB-Sant Pau) and Josep Carreras Research Institute; Hospital de la Santa Creu i Sant Pau; 08025 Barcelona Spain

5. Servei de Microscòpia; Universitat Autònoma de Barcelona; Bellaterra 08193 Barcelona Spain

6. Instituto de Investigaciones Biológicas y Tecnológicas (IIBYT) (CONICET-Universidad Nacional de Córdoba), ICTA and Cátedra de Química Biológica; Departamento de Química; FCEFyN, UNC, Av. Velez Sarsfield 1611 X 5016GCA Córdoba Argentina

Funder

Albert Ellis Institute

European Regional Development Fund

Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina

Fundación Española de Hematología y Hemoterapia

Publisher

Wiley

Subject

Biomaterials,Biotechnology,General Materials Science,General Chemistry

Reference67 articles.

1. Drug-induced hepatotoxicity in cancer patients - implication for treatment

2. Protein-Based Therapeutic Killing for Cancer Therapies